HLS Therapeutics Inc
OTC:HLTRF

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
OTC:HLTRF
Watchlist
Price: 3 USD Market Closed
Market Cap: $95.4m

Profitability Summary

HLS Therapeutics Inc's profitability score is 30/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

30 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

30 / 100
Profitability
Score
30 / 100
Profitability
Score

Margins

Earnings Waterfall
HLS Therapeutics Inc

Margins Comparison
HLS Therapeutics Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CA
HLS Therapeutics Inc
TSX:HLS
137m CAD
Loading...
Loading...
Loading...
US
Mckesson Corp
NYSE:MCK
105.8B USD
Loading...
Loading...
Loading...
US
Cencora Inc
NYSE:COR
60.3B USD
Loading...
Loading...
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
60.7B USD
Loading...
Loading...
Loading...
US
Cardinal Health Inc
NYSE:CAH
48.7B USD
Loading...
Loading...
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
30.1B AUD
Loading...
Loading...
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
62.2B CNY
Loading...
Loading...
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
61.9B CNY
Loading...
Loading...
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
8.4B USD
Loading...
Loading...
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
63.5B HKD
Loading...
Loading...
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
HLS Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CA
HLS Therapeutics Inc
TSX:HLS
137m CAD
Loading...
Loading...
Loading...
Loading...
US
Mckesson Corp
NYSE:MCK
105.8B USD
Loading...
Loading...
Loading...
Loading...
US
Cencora Inc
NYSE:COR
60.3B USD
Loading...
Loading...
Loading...
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
60.7B USD
Loading...
Loading...
Loading...
Loading...
US
Cardinal Health Inc
NYSE:CAH
48.7B USD
Loading...
Loading...
Loading...
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
30.1B AUD
Loading...
Loading...
Loading...
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
62.2B CNY
Loading...
Loading...
Loading...
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
61.9B CNY
Loading...
Loading...
Loading...
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
8.4B USD
Loading...
Loading...
Loading...
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
63.5B HKD
Loading...
Loading...
Loading...
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
HLS Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett